{
  "meta": {
    "id": "test56",
    "title": "Mid Day Module (OBG-3) - 2025-03-04",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "All are risk factors for progression of Hydatidiform mole to gestational trophoblastic neoplasia except?",
      "options": [
        {
          "label": "A",
          "text": "\u03b2hCG levels > 100,000",
          "correct": false
        },
        {
          "label": "B",
          "text": "Slow decline in \u03b2hCG levels",
          "correct": false
        },
        {
          "label": "C",
          "text": "Theca lutein cyst > 6 cm",
          "correct": false
        },
        {
          "label": "D",
          "text": "Younger maternal age",
          "correct": true
        }
      ],
      "correct_answer": "D. Younger maternal age",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Younger maternal age</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk Factors for progress to GTN</li><li>\u27a4 Risk Factors for progress to GTN</li><li>\u27a4 Complete mole (15%) > Partial mole (5%) Older Maternal Age \u03b2hCG levels > 100,000 Uterine size large for gestational age Theca lutein cysts > 6 cm Slow decline in \u03b2hCG levels</li><li>\u27a4 Complete mole (15%) > Partial mole (5%)</li><li>\u27a4 Older Maternal Age</li><li>\u27a4 \u03b2hCG levels > 100,000</li><li>\u27a4 Uterine size large for gestational age</li><li>\u27a4 Theca lutein cysts > 6 cm</li><li>\u27a4 Slow decline in \u03b2hCG levels</li><li>\u27a4 Ref: page no 393, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 393, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2112c3f4",
      "audio": ""
    },
    {
      "text": "A 36-year-old woman presents to the OPD with complaints of 3 months pregnancy with vaginal bleeding. On examination, the uterus is palpable. An ultrasound shows the following picture. What is the best management option?",
      "options": [
        {
          "label": "A",
          "text": "Mifepristone + Misoprostol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Conservative management",
          "correct": false
        },
        {
          "label": "C",
          "text": "Suction & Evacuation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hysterotomy",
          "correct": false
        }
      ],
      "correct_answer": "C. Suction & Evacuation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/4.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Treatment of a molar pregnancy is suction and evacuation followed by beta hCG surveilance</li><li>\u27a4 Ref: Page no. 391, 392 William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no. 391, 392 William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fad818eb",
      "audio": ""
    },
    {
      "text": "Paternal chromosomal duplication is seen in?",
      "options": [
        {
          "label": "A",
          "text": "Partial mole",
          "correct": false
        },
        {
          "label": "B",
          "text": "Complete mole",
          "correct": true
        },
        {
          "label": "C",
          "text": "Down syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Turner Syndrome",
          "correct": false
        }
      ],
      "correct_answer": "B. Complete mole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Complete mole</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Partial moles are always TRIPLOID 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present Usually, 69XXX or 69XXY Complete moles are DIPLOID Formed by either 1 sperm fertilizing an empty/ inactivated ovum and then undergoes duplication \u2013 this is called androgenesis.</li><li>\u27a4 Partial moles are always TRIPLOID 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present Usually, 69XXX or 69XXY</li><li>\u27a4 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present Usually, 69XXX or 69XXY</li><li>\u27a4 2 sperm fertilize one ova</li><li>\u27a4 The paternal contribution is called diandry</li><li>\u27a4 Hence both maternal and paternal component present</li><li>\u27a4 Usually, 69XXX or 69XXY</li><li>\u27a4 Complete moles are DIPLOID Formed by either 1 sperm fertilizing an empty/ inactivated ovum and then undergoes duplication \u2013 this is called androgenesis.</li><li>\u27a4 Formed by either 1 sperm fertilizing an empty/ inactivated ovum and then undergoes duplication \u2013 this is called androgenesis.</li><li>\u27a4 Formed by either 1 sperm fertilizing an empty/ inactivated ovum and then undergoes duplication \u2013 this is called androgenesis.</li><li>\u27a4 2 sperms (dispermy) fertilize an empty/ inactivated ovum. 46 XX or 46 XY Only paternal component No maternal component</li><li>\u27a4 2 sperms (dispermy) fertilize an empty/ inactivated ovum.</li><li>\u27a4 46 XX or 46 XY</li><li>\u27a4 Only paternal component</li><li>\u27a4 No maternal component</li><li>\u27a4 Ref: Page no 389, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 389, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1cc44113",
      "audio": ""
    },
    {
      "text": "During post evacuation surveillance following evacuation of a complete mole, the median time for resolution of serum \u03b2hCG values is:",
      "options": [
        {
          "label": "A",
          "text": "6 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "7 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "8 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "9 weeks",
          "correct": true
        }
      ],
      "correct_answer": "D. 9 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. 9 weeks</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45994ee4",
      "audio": ""
    },
    {
      "text": "A 23y woman has a suction evacuation for molar pregnancy. The HPE is reported as a partial mole. You counsel her that her risk of progression to gestational trophoblastic neoplasia is?",
      "options": [
        {
          "label": "A",
          "text": "1-5%",
          "correct": true
        },
        {
          "label": "B",
          "text": "5-10%",
          "correct": false
        },
        {
          "label": "C",
          "text": "10-15%",
          "correct": false
        },
        {
          "label": "D",
          "text": "15-20%",
          "correct": false
        }
      ],
      "correct_answer": "A. 1-5%",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. 1-5%</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk of progress of complete mole to GTN: 15-20 % Risk of progress of partial mole to GTN: 1-5%</li><li>\u27a4 Risk of progress of complete mole to GTN: 15-20 %</li><li>\u27a4 Risk of progress of partial mole to GTN: 1-5%</li><li>\u27a4 Ref: Page 393, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 393, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d452f62f",
      "audio": ""
    },
    {
      "text": "Identify the ultrasound finding:",
      "options": [
        {
          "label": "A",
          "text": "Ring of Pearls appearance",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rokitansky nodule",
          "correct": false
        },
        {
          "label": "C",
          "text": "Snowstorm appearance",
          "correct": true
        },
        {
          "label": "D",
          "text": "Waterlily sign",
          "correct": false
        }
      ],
      "correct_answer": "C. Snowstorm appearance",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/21.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/21.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Snowstorm appearance</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This image shows the typical snowstorm appearance seen on ultrasound in complete molar pregnancy</li><li>\u27a4 Ref: Williams textbook of obstetrics, 26 edition, chapter 13.</li><li>\u27a4 Ref: Williams textbook of obstetrics, 26 edition, chapter 13.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe00cc14",
      "audio": ""
    },
    {
      "text": "A woman with molar pregnancy is undergoing suction evacuation. Suddenly she develops breathing difficulty, tachypnoea and falls in saturation. The most likely cause is:",
      "options": [
        {
          "label": "A",
          "text": "Fluid overload",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metastatic disease suggestive of GTN",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thyroid storm",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trophoblastic embolization",
          "correct": true
        }
      ],
      "correct_answer": "D. Trophoblastic embolization",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Trophoblastic embolization</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b25e2b50",
      "audio": ""
    },
    {
      "text": "Identify the instrument:",
      "options": [
        {
          "label": "A",
          "text": "Curette",
          "correct": false
        },
        {
          "label": "B",
          "text": "Karman cannula",
          "correct": true
        },
        {
          "label": "C",
          "text": "Manual vacuum aspiration syringe",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pipelle suction curette",
          "correct": false
        }
      ],
      "correct_answer": "B. Karman cannula",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/22.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Karman cannula</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "636ab3e0",
      "audio": ""
    },
    {
      "text": "Gestational trophoblastic neoplasia includes all Except:",
      "options": [
        {
          "label": "A",
          "text": "Choriocarcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Epithelioid trophoblastic tumor (ETT)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Molar pregnancy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Placental site trophoblastic tumor (PSTT)",
          "correct": false
        }
      ],
      "correct_answer": "C. Molar pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. molar pregnancy</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a41766d6",
      "audio": ""
    },
    {
      "text": "Mean pH of vagina during pregnancy is?",
      "options": [
        {
          "label": "A",
          "text": "4",
          "correct": true
        },
        {
          "label": "B",
          "text": "5",
          "correct": false
        },
        {
          "label": "C",
          "text": "6",
          "correct": false
        },
        {
          "label": "D",
          "text": "7",
          "correct": false
        }
      ],
      "correct_answer": "A. 4",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-181345.jpg"
      ],
      "explanation": "<p><strong>Ans. A. 4</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Vagina</li><li>\u2022 Vagina</li><li>\u2022 Acidic pH (3.5 \u2013 6): due to conversion of glycogen into lactic acid by the Lactobacillus acidophilus (due to high estrogen level )</li><li>\u2022 Acidic pH (3.5 \u2013 6): due to conversion of glycogen into lactic acid by the Lactobacillus acidophilus (due to high estrogen level )</li><li>\u2022 Acidic pH (3.5 \u2013 6):</li><li>\u2022 glycogen into lactic acid</li><li>\u2022 Lactobacillus acidophilus</li><li>\u2022 high estrogen level</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 52, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 52, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "70dd3ff5",
      "audio": ""
    },
    {
      "text": "All are true about hemodynamic changes in pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Increase in ventricular stroke volume",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase in systemic vascular resistance",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cardiac output is higher in lateral recumbent than supine position",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increase in heart rate",
          "correct": false
        }
      ],
      "correct_answer": "B. Increase in systemic vascular resistance",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Increase in systemic vascular resistance</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u2022 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u2022 Systemic vascular resistance</li><li>\u2022 reduced</li><li>\u2022 fall in BP</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: Increase in ventricular stroke volume: The stroke volume is increased in pregnancy Option C: Cardiac output is higher in lateral recumbent than supine position: This is because in supine position there is c ompression of the aorta and the IVC Option D: Increase in heart rate : The heart rate increases in pregnancy</li><li>\u2022 Option A: Increase in ventricular stroke volume: The stroke volume is increased in pregnancy</li><li>\u2022 Option A:</li><li>\u2022 Increase in ventricular stroke volume:</li><li>\u2022 increased</li><li>\u2022 pregnancy</li><li>\u2022 Option C: Cardiac output is higher in lateral recumbent than supine position: This is because in supine position there is c ompression of the aorta and the IVC</li><li>\u2022 Option C:</li><li>\u2022 Cardiac output</li><li>\u2022 higher</li><li>\u2022 lateral recumbent</li><li>\u2022 supine position</li><li>\u2022 ompression of the aorta</li><li>\u2022 IVC</li><li>\u2022 Option D: Increase in heart rate : The heart rate increases in pregnancy</li><li>\u2022 Option D:</li><li>\u2022 Increase</li><li>\u2022 heart rate</li><li>\u2022 increases</li><li>\u2022 pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u27a4 Systemic vascular resistance is reduced in pregnancy thereby causing a fall in BP</li><li>\u27a4 Systemic vascular resistance</li><li>\u27a4 reduced</li><li>\u27a4 pregnancy</li><li>\u27a4 fall in BP</li><li>\u27a4 Ref: Page 58, Williams Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 58, Williams Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2b802ac6",
      "audio": ""
    },
    {
      "text": "Which of the following best describes the function of pregnancy associated plasma protein A (PAPP-A)?",
      "options": [
        {
          "label": "A",
          "text": "Carrier protein for estrogen and progesterone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Helps in maintenance of placenta",
          "correct": false
        },
        {
          "label": "C",
          "text": "Immunosuppression against fetal antigens",
          "correct": true
        },
        {
          "label": "D",
          "text": "Maintains colloid osmotic pressure in maternal blood",
          "correct": false
        }
      ],
      "correct_answer": "C. Immunosuppression against fetal antigens",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Immunosuppression against fetal antigens</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Pregnancy-associated plasma protein-A (PAPP-A) largest of the pregnancy associated proteins is produced by both the embryo and the placenta (syncytio-cytotrophoblasts) during pregnancy. This protein is thought to have several different functions, including preventing recognition of the fetus by the maternal immune system, matrix mineralization and angiogenesis. Levels of PAPP-A rise from first detection in the first trimester until term. Maternal serum concentrations are related to subsequent fetal growth and this relationship has suggested that it can be used as a diagnostic test for adverse pregnancy outcomes ( intrauterine growth restriction, premature birth, preeclampsia, and stillbirth ).</li><li>\u27a4 Pregnancy-associated plasma protein-A (PAPP-A) largest of the pregnancy associated proteins is produced by both the embryo and the placenta (syncytio-cytotrophoblasts) during pregnancy.</li><li>\u27a4 Pregnancy-associated plasma protein-A (PAPP-A)</li><li>\u27a4 pregnancy</li><li>\u27a4 proteins</li><li>\u27a4 both</li><li>\u27a4 embryo and the placenta (syncytio-cytotrophoblasts)</li><li>\u27a4 This protein is thought to have several different functions, including preventing recognition of the fetus by the maternal immune system, matrix mineralization and angiogenesis.</li><li>\u27a4 preventing recognition of the fetus</li><li>\u27a4 maternal</li><li>\u27a4 immune system, matrix mineralization and angiogenesis.</li><li>\u27a4 Levels of PAPP-A rise from first detection in the first trimester until term.</li><li>\u27a4 PAPP-A rise</li><li>\u27a4 first</li><li>\u27a4 first trimester until term.</li><li>\u27a4 Maternal serum concentrations are related to subsequent fetal growth and this relationship has suggested that it can be used as a diagnostic test for adverse pregnancy outcomes ( intrauterine growth restriction, premature birth, preeclampsia, and stillbirth ).</li><li>\u27a4 Maternal serum concentrations</li><li>\u27a4 fetal growth</li><li>\u27a4 diagnostic test</li><li>\u27a4 pregnancy outcomes</li><li>\u27a4 intrauterine growth restriction, premature birth,</li><li>\u27a4 preeclampsia, and stillbirth</li><li>\u27a4 Ref: Page no 863, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 863, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cccdcaf7",
      "audio": ""
    },
    {
      "text": "All are risk factors for tubal ectopic pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Endometriosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "History of salpingitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Previous ectopic pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Previous cesarean",
          "correct": true
        }
      ],
      "correct_answer": "D. Previous cesarean",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Previous cesarean</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Previous cesarean section is NOT a risk factor for tubal ectopic pregnancy</li><li>\u2022 Previous cesarean section is NOT a risk factor for tubal ectopic pregnancy</li><li>\u2022 Let\u2019s Discuss all the other options:</li><li>\u2022 Let\u2019s Discuss all the other options:</li><li>\u2022 Option A: Endometriosis affects tubal motility due to adhesions and thus increases the risk of ectopic pregnancy Option B: Salpingitis is inflammation of the fallopian tube. A past h/o salpingitis may have led to tubal damage and hence affect tubal motility thereby leading to a higher risk of tubal ectopic Option C: Previous h/o ectopic is also a risk factor for a repeat tubal ectopic as it means there is an underlying pathology</li><li>\u2022 Option A: Endometriosis affects tubal motility due to adhesions and thus increases the risk of ectopic pregnancy</li><li>\u2022 Option A:</li><li>\u2022 Option B: Salpingitis is inflammation of the fallopian tube. A past h/o salpingitis may have led to tubal damage and hence affect tubal motility thereby leading to a higher risk of tubal ectopic</li><li>\u2022 Option B:</li><li>\u2022 Option C: Previous h/o ectopic is also a risk factor for a repeat tubal ectopic as it means there is an underlying pathology</li><li>\u2022 Option C:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk Factors of ectopic pregnancy</li><li>\u27a4 Risk Factors of ectopic pregnancy</li><li>\u27a4 h/o Tubal Surgery (e.g., for fertility restoration or sterilization): As per Williams Obstetrics 25 th edition (page 371): HIGHEST RISK Prior h/o salpingitis: 6 \u2013 10-fold increased risk h/o previous ectopic: 5-fold risk (10 \u2013 15% chance of repeat ectopic) Peri tubal adhesions (like endometriosis) Salpingitis isthmica nodosa Congenital tubal anomalies Infertility (artificial Reproductive techniques like IVF) Associated with Atypical implantations and heterotopic pregnancies Contraception: Relative numbers increased with intra-uterine devices (Absolute numbers decreased) Intra uterine devices Progesterone only pill</li><li>\u27a4 h/o Tubal Surgery (e.g., for fertility restoration or sterilization): As per Williams Obstetrics 25 th edition (page 371): HIGHEST RISK</li><li>\u27a4 h/o Tubal Surgery (e.g., for fertility restoration or sterilization): As per Williams Obstetrics 25 th edition (page 371): HIGHEST RISK</li><li>\u27a4 Prior h/o salpingitis: 6 \u2013 10-fold increased risk</li><li>\u27a4 h/o previous ectopic: 5-fold risk (10 \u2013 15% chance of repeat ectopic)</li><li>\u27a4 Peri tubal adhesions (like endometriosis)</li><li>\u27a4 Salpingitis isthmica nodosa</li><li>\u27a4 Congenital tubal anomalies</li><li>\u27a4 Infertility (artificial Reproductive techniques like IVF) Associated with Atypical implantations and heterotopic pregnancies</li><li>\u27a4 Associated with Atypical implantations and heterotopic pregnancies</li><li>\u27a4 Associated with Atypical implantations and heterotopic pregnancies</li><li>\u27a4 Contraception: Relative numbers increased with intra-uterine devices (Absolute numbers decreased) Intra uterine devices Progesterone only pill</li><li>\u27a4 Intra uterine devices Progesterone only pill</li><li>\u27a4 Intra uterine devices</li><li>\u27a4 Progesterone only pill</li><li>\u27a4 Ref: Page 371, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 371, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a056c3b0",
      "audio": ""
    },
    {
      "text": "A 24y lady presented to the emergency with generalized pain and spotting PV. Her LMP was 2 months back and she has a history of irregular cycles. On examination, she is pale, her PR is 110/ min, BP is 80/60 mmHg. There is guarding and rigidity on abdominal examination and a vaginal exam reveals cervical motion tenderness. Her urine pregnancy test is weakly positive. What is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Dilatation and evacuation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Shift to the O.T. for an emergency laparotomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Urgent ultrasound",
          "correct": false
        },
        {
          "label": "D",
          "text": "Urgent serum \u03b2hCG",
          "correct": false
        }
      ],
      "correct_answer": "B. Shift to the O.T. for an emergency laparotomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This is most likely a ruptured ectopic pregnancy. A RUPTURED ectopic pregnancy is a clinical diagnosis. Whenever there is a ruptured ectopic pregnancy with the patient in shock (hypotension, tachycardia), no time is to be wasted and the patient should be shifted to the OT for an emergency laparoscopy/ laparotomy and salpingectomy.</li><li>\u2022 This is most likely a ruptured ectopic pregnancy. A RUPTURED ectopic pregnancy is a clinical diagnosis.</li><li>\u2022 Whenever there is a ruptured ectopic pregnancy with the patient in shock (hypotension, tachycardia), no time is to be wasted and the patient should be shifted to the OT for an emergency laparoscopy/ laparotomy and salpingectomy.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Dilatation and evacuation: This is not done in an ectopic pregnancy Option C: Doing an ultrasound (no matter how urgently in a patient with shock) will cause a delay and worsen patient prognosis Option D: Beta hCG (even urgent will take a few hours) is not indicated in a ruptured ectopic. It only has a role in an unruptured ectopic</li><li>\u2022 Option A: Dilatation and evacuation: This is not done in an ectopic pregnancy</li><li>\u2022 Option A:</li><li>\u2022 Option C: Doing an ultrasound (no matter how urgently in a patient with shock) will cause a delay and worsen patient prognosis</li><li>\u2022 Option C:</li><li>\u2022 Option D: Beta hCG (even urgent will take a few hours) is not indicated in a ruptured ectopic. It only has a role in an unruptured ectopic</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 D/d of bleeding in the 1 st trimester</li><li>\u27a4 Implantation bleeding (Placental Sign) Abortion (threatened, inevitable, incomplete, complete, missed) Ectopic Pregnancy Molar pregnancy</li><li>\u27a4 Implantation bleeding (Placental Sign)</li><li>\u27a4 Abortion (threatened, inevitable, incomplete, complete, missed)</li><li>\u27a4 Ectopic Pregnancy</li><li>\u27a4 Molar pregnancy</li><li>\u27a4 Classic triad of symptoms I.e., pain, bleeding and delayed menstruation is seen in an ectopic pregnancy. In this scenario there is pain and bleeding with a positive pregnancy test and on examination there is pallor, shock and intraperitoneal bleed which points to a ruptured ectopic pregnancy. Next best management option is immediate surgical management and salpingectomy</li><li>\u27a4 Classic triad of symptoms I.e., pain, bleeding and delayed menstruation is seen in an ectopic pregnancy.</li><li>\u27a4 In this scenario there is pain and bleeding with a positive pregnancy test and on examination there is pallor, shock and intraperitoneal bleed which points to a ruptured ectopic pregnancy.</li><li>\u27a4 Next best management option is immediate surgical management and salpingectomy</li><li>\u27a4 Ref: Page 371, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 371, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6ae21011",
      "audio": ""
    },
    {
      "text": "The classic triad of clinical features in an ectopic pregnancy is:",
      "options": [
        {
          "label": "A",
          "text": "Pain, bleeding, pallor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pain, delayed menstruation, pallor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bleeding, pain, delayed menstruation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pallor, pain, delayed menstruation",
          "correct": false
        }
      ],
      "correct_answer": "C. Bleeding, pain, delayed menstruation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Clinical Features of an ectopic pregnancy vary but is typically characterized by the classic triad of Delayed menstruation Abdominal pain Vaginal Bleeding</li><li>\u2022 Clinical Features of an ectopic pregnancy vary but is typically characterized by the classic triad of Delayed menstruation Abdominal pain Vaginal Bleeding</li><li>\u2022 Clinical Features of an ectopic pregnancy vary but is typically characterized by the classic triad of</li><li>\u2022 Delayed menstruation Abdominal pain Vaginal Bleeding</li><li>\u2022 Delayed menstruation</li><li>\u2022 Abdominal pain</li><li>\u2022 Vaginal Bleeding</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Clinical Features of an ectopic pregnancy vary but is typically characterized by the classic triad of Delayed menstruation Abdominal pain Vaginal Bleeding Other symptoms may include: Passage of a decidual cast Severe hemoperitoneum: diaphragmatic irritation \u2013 shoulder pain Pallor, Shock \u2013 uterine rupture Abdominal tenderness Bimanual exam: cervical motion tenderness Tender boggy mass in the post fornix (collected blood) Cullen\u2019s sign: Periumbilical bluish discoloration due to intraperitoneal bleeding</li><li>\u27a4 Clinical Features of an ectopic pregnancy vary but is typically characterized by the classic triad of Delayed menstruation Abdominal pain Vaginal Bleeding</li><li>\u27a4 Clinical Features of an ectopic pregnancy vary but is typically characterized by the classic triad of</li><li>\u27a4 Delayed menstruation Abdominal pain Vaginal Bleeding</li><li>\u27a4 Delayed menstruation</li><li>\u27a4 Abdominal pain</li><li>\u27a4 Vaginal Bleeding</li><li>\u27a4 Other symptoms may include: Passage of a decidual cast Severe hemoperitoneum: diaphragmatic irritation \u2013 shoulder pain Pallor, Shock \u2013 uterine rupture Abdominal tenderness Bimanual exam: cervical motion tenderness Tender boggy mass in the post fornix (collected blood) Cullen\u2019s sign: Periumbilical bluish discoloration due to intraperitoneal bleeding</li><li>\u27a4 Passage of a decidual cast Severe hemoperitoneum: diaphragmatic irritation \u2013 shoulder pain Pallor, Shock \u2013 uterine rupture Abdominal tenderness Bimanual exam: cervical motion tenderness Tender boggy mass in the post fornix (collected blood) Cullen\u2019s sign: Periumbilical bluish discoloration due to intraperitoneal bleeding</li><li>\u27a4 Passage of a decidual cast</li><li>\u27a4 Severe hemoperitoneum: diaphragmatic irritation \u2013 shoulder pain</li><li>\u27a4 Pallor, Shock \u2013 uterine rupture</li><li>\u27a4 Abdominal tenderness</li><li>\u27a4 Bimanual exam: cervical motion tenderness</li><li>\u27a4 Tender boggy mass in the post fornix (collected blood)</li><li>\u27a4 Cullen\u2019s sign: Periumbilical bluish discoloration due to intraperitoneal bleeding</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b7e58cc9",
      "audio": ""
    },
    {
      "text": "All are ultrasound signs of an unruptured ectopic pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Bagel sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blob sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lemon sign",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tubal ring",
          "correct": false
        }
      ],
      "correct_answer": "C. Lemon sign",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Let\u2019s Discuss all the Options:</li><li>\u2022 Option A: Bagel sign: This is a \u2018bagel\u2019 or doughnut shaped structure seen in the adnexa on ultrasound typical of an unruptured ectopic pregnancy Option B: Blob sign: This is also a sign seen in ectopic pregnancy wherein a Heteroechoic structure is seen in the adnexal region Option C: Lemon sign: This is a sign seen in spina bifida which shows pinching of the calvarium Option D: Tubal ring: This is a ring like structure on ultrasound seen in ectopic pregnancy</li><li>\u2022 Option A: Bagel sign: This is a \u2018bagel\u2019 or doughnut shaped structure seen in the adnexa on ultrasound typical of an unruptured ectopic pregnancy</li><li>\u2022 Option A:</li><li>\u2022 Option B: Blob sign: This is also a sign seen in ectopic pregnancy wherein a Heteroechoic structure is seen in the adnexal region</li><li>\u2022 Option B:</li><li>\u2022 Option C: Lemon sign: This is a sign seen in spina bifida which shows pinching of the calvarium</li><li>\u2022 Option C:</li><li>\u2022 Option D: Tubal ring: This is a ring like structure on ultrasound seen in ectopic pregnancy</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In Suspected unruptured ectopic pregnancy: Trans-vaginal Sonography (TVS) will reveal</li><li>\u27a4 An absent intra-uterine pregnancy The presence of a pseudo-sac in the uterine cavity The presence of an adnexal mass separate from the ovary Hyperechoic ring surrounding an anechoic sac- seen in 20% (bagel sign/tubal ring sign) Inhomogeneous mass \u2013 60% (blob sign) Obvious gestational sac with a fetal pole \u2013 13% On color doppler: \u201cRing of fire\u201d seen. (D/d \u2013 Corpus luteal cyst)</li><li>\u27a4 An absent intra-uterine pregnancy</li><li>\u27a4 The presence of a pseudo-sac in the uterine cavity</li><li>\u27a4 The presence of an adnexal mass separate from the ovary Hyperechoic ring surrounding an anechoic sac- seen in 20% (bagel sign/tubal ring sign) Inhomogeneous mass \u2013 60% (blob sign) Obvious gestational sac with a fetal pole \u2013 13%</li><li>\u27a4 Hyperechoic ring surrounding an anechoic sac- seen in 20% (bagel sign/tubal ring sign) Inhomogeneous mass \u2013 60% (blob sign) Obvious gestational sac with a fetal pole \u2013 13%</li><li>\u27a4 Hyperechoic ring surrounding an anechoic sac- seen in 20% (bagel sign/tubal ring sign)</li><li>\u27a4 Inhomogeneous mass \u2013 60% (blob sign)</li><li>\u27a4 Obvious gestational sac with a fetal pole \u2013 13%</li><li>\u27a4 On color doppler: \u201cRing of fire\u201d seen. (D/d \u2013 Corpus luteal cyst)</li><li>\u27a4 Ref: page no 375, William Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 375, William Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c196b0e",
      "audio": ""
    },
    {
      "text": "The value of \u03b2hCG above which an intra-uterine gestational sac should be seen is:",
      "options": [
        {
          "label": "A",
          "text": "500 IU/L",
          "correct": false
        },
        {
          "label": "B",
          "text": "1500 IU/L",
          "correct": true
        },
        {
          "label": "C",
          "text": "2500 IU/L",
          "correct": false
        },
        {
          "label": "D",
          "text": "3500 IU/L",
          "correct": false
        }
      ],
      "correct_answer": "B. 1500 IU/L",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 1500 IU/L</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Discriminatory Zone: This is the level of serum \u03b2hCG above which an intra uterine gestational sac should be seen,</li><li>\u2022 Discriminatory Zone:</li><li>\u2022 1500 \u2013 2000 IU/L for TVS 5000 \u2013 6000 IU/L for TAS</li><li>\u2022 1500 \u2013 2000 IU/L for TVS</li><li>\u2022 1500 \u2013 2000 IU/L for TVS</li><li>\u2022 5000 \u2013 6000 IU/L for TAS</li><li>\u2022 5000 \u2013 6000 IU/L for TAS</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Discriminatory Zone: This is the level of serum \u03b2hCG above which an intra uterine gestational sac should be seen, 1500 \u2013 2000 IU/L for TVS 5000 \u2013 6000 IU/L for TAS</li><li>\u27a4 Discriminatory Zone: This is the level of serum \u03b2hCG above which an intra uterine gestational sac should be seen, 1500 \u2013 2000 IU/L for TVS 5000 \u2013 6000 IU/L for TAS</li><li>\u27a4 Discriminatory Zone:</li><li>\u27a4 1500 \u2013 2000 IU/L for TVS 5000 \u2013 6000 IU/L for TAS</li><li>\u27a4 1500 \u2013 2000 IU/L for TVS</li><li>\u27a4 1500 \u2013 2000 IU/L for TVS</li><li>\u27a4 5000 \u2013 6000 IU/L for TAS</li><li>\u27a4 5000 \u2013 6000 IU/L for TAS</li><li>\u27a4 Ref: page no 373, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 373, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9308e803",
      "audio": ""
    },
    {
      "text": "A 20y G2A1 presents at 6 weeks pregnancy with vaginal bleeding. On TVS, no gestational sac is visualized. Her serum \u03b2hCG is 2000 IU/L. Which is NOT a possible diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "A failing intrauterine pregnancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "A Hydatiform mole",
          "correct": true
        },
        {
          "label": "C",
          "text": "A recent complete abortion",
          "correct": false
        },
        {
          "label": "D",
          "text": "An ectopic pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "B. A Hydatiform mole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Discriminatory Zone: This is the level of serum \u03b2hCG above which an intra uterine gestational sac should be seen, 1500 \u2013 2000 IU/L for TVS 5000 \u2013 6000 IU/L for TAS So, if serum \u03b2hCG levels are more than the discriminatory zone and still an intrauterine gestational sac is not seen on ultrasound, it is called a pregnancy of undetermined location & the following should be suspected: Ectopic pregnancy Failing intrauterine pregnancy Recent complete abortion Early multifetal pregnancy</li><li>\u2022 Discriminatory Zone: This is the level of serum \u03b2hCG above which an intra uterine gestational sac should be seen, 1500 \u2013 2000 IU/L for TVS 5000 \u2013 6000 IU/L for TAS</li><li>\u2022 Discriminatory Zone:</li><li>\u2022 1500 \u2013 2000 IU/L for TVS 5000 \u2013 6000 IU/L for TAS</li><li>\u2022 1500 \u2013 2000 IU/L for TVS</li><li>\u2022 1500 \u2013 2000 IU/L for TVS</li><li>\u2022 5000 \u2013 6000 IU/L for TAS</li><li>\u2022 5000 \u2013 6000 IU/L for TAS</li><li>\u2022 So, if serum \u03b2hCG levels are more than the discriminatory zone and still an intrauterine gestational sac is not seen on ultrasound, it is called a pregnancy of undetermined location & the following should be suspected: Ectopic pregnancy Failing intrauterine pregnancy Recent complete abortion Early multifetal pregnancy</li><li>\u2022 pregnancy of undetermined location</li><li>\u2022 Ectopic pregnancy Failing intrauterine pregnancy Recent complete abortion Early multifetal pregnancy</li><li>\u2022 Ectopic pregnancy</li><li>\u2022 Failing intrauterine pregnancy</li><li>\u2022 Recent complete abortion</li><li>\u2022 Early multifetal pregnancy</li><li>\u2022 Other option</li><li>\u2022 Other option</li><li>\u2022 In molar pregnancy, the \u03b2hCG levels are very high (usually > 100,000)</li><li>\u2022 In molar pregnancy, the \u03b2hCG levels are very high (usually > 100,000)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 If serum \u03b2hCG levels are more than the discriminatory zone and still an intrauterine gestational sac is not seen on ultrasound, it is called a pregnancy of undetermined location & the following should be suspected: Ectopic pregnancy Failing intrauterine pregnancy Recent complete abortion Early multifetal pregnancy</li><li>\u27a4 If serum \u03b2hCG levels are more than the discriminatory zone and still an intrauterine gestational sac is not seen on ultrasound, it is called a pregnancy of undetermined location & the following should be suspected: Ectopic pregnancy Failing intrauterine pregnancy Recent complete abortion Early multifetal pregnancy</li><li>\u27a4 pregnancy of undetermined location</li><li>\u27a4 Ectopic pregnancy Failing intrauterine pregnancy Recent complete abortion Early multifetal pregnancy</li><li>\u27a4 Ectopic pregnancy</li><li>\u27a4 Failing intrauterine pregnancy</li><li>\u27a4 Recent complete abortion</li><li>\u27a4 Early multifetal pregnancy</li><li>\u27a4 Ref: page no 374, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 374, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5581ee8d",
      "audio": ""
    },
    {
      "text": "A 34-year woman presents to the gyn OPD with an unruptured tubal ectopic pregnancy. She has no symptoms and is hemodynamically stable. Her \u03b2hCG is 600 IU/L. The ultrasound shows a gestational sac measuring 20 mm in the right adnexa with no yolk sac or embryo seen. Which of these is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Expectant management",
          "correct": true
        },
        {
          "label": "B",
          "text": "Single dose inj Methotrexate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Laparoscopic salpingostomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Laparoscopic salpingectomy",
          "correct": false
        }
      ],
      "correct_answer": "A. Expectant management",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Expectant management</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This patient fulfills all the criteria for Expectant management, i.e. no active intervention needs to be done. Just following up with weekly beta hCG levels (it should decrease every week)</li><li>\u2022 Let\u2019s discuss the other options</li><li>\u2022 Let\u2019s discuss the other options</li><li>\u2022 Option B: Single dose inj Methotrexate: This is medical management and is indicated in an unruptured ectopic pregnancy with:</li><li>\u2022 Option B: Single dose inj Methotrexate: This is medical management and is indicated in an unruptured ectopic pregnancy with:</li><li>\u2022 Option B:</li><li>\u2022 Patient hemodynamically stable No significant symptoms Gestational sac size < 3.5 cm No visible cardiac activity Serum \u03b2hCG < 5000 IU/L No contraindication to Methotrexate (Anemia, liver disease, bleeding disorder, active pulmonary disease etc.)</li><li>\u2022 Patient hemodynamically stable</li><li>\u2022 No significant symptoms</li><li>\u2022 Gestational sac size < 3.5 cm</li><li>\u2022 No visible cardiac activity</li><li>\u2022 Serum \u03b2hCG < 5000 IU/L</li><li>\u2022 No contraindication to Methotrexate (Anemia, liver disease, bleeding disorder, active pulmonary disease etc.)</li><li>\u2022 Option C and D: Laparoscopic salpingostomy/ salpingectomy: Surgical management in an unruptured ectopic is indicated in a woman with an unruptured ectopic pregnancy with</li><li>\u2022 Option C and D: Laparoscopic salpingostomy/ salpingectomy: Surgical management in an unruptured ectopic is indicated in a woman with an unruptured ectopic pregnancy with</li><li>\u2022 Option C and D: Laparoscopic salpingostomy/ salpingectomy:</li><li>\u2022 Significant pain OR Gestational sac size > 3.5 cm OR Visible cardiac activity on ultrasound OR Hemodynamically unstable patient OR Beta hCG > 5000 IU/L</li><li>\u2022 Significant pain OR</li><li>\u2022 Gestational sac size > 3.5 cm OR</li><li>\u2022 Visible cardiac activity on ultrasound OR</li><li>\u2022 Hemodynamically unstable patient OR</li><li>\u2022 Beta hCG > 5000 IU/L</li><li>\u2022 The choice between salpingotomy or salpingectomy is made based on the following: Salpingectomy (Removing the whole tube) is preferred In women whose family is complete, if the tube is grossly distorted anatomically, if the ectopic has happened at the sire of a previous ectopic or at the site of a previous tubal ligation.</li><li>\u2022 The choice between salpingotomy or salpingectomy is made based on the following: Salpingectomy (Removing the whole tube) is preferred In women whose family is complete, if the tube is grossly distorted anatomically, if the ectopic has happened at the sire of a previous ectopic or at the site of a previous tubal ligation.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Expectant Management</li><li>\u27a4 Expectant Management</li><li>\u27a4 Only for clinically stable asymptomatic women with an ultrasound diagnosis of ectopic pregnancy with the following features</li><li>\u27a4 Only for clinically stable asymptomatic women with an ultrasound diagnosis of ectopic pregnancy with the following features</li><li>\u27a4 Clinically stable with No pain AND Serum \u03b2hCG < 1000 IU/L AND Tubal ectopic < 35mm with no visible heartbeat AND Able to return for follow up</li><li>\u27a4 Clinically stable with No pain AND</li><li>\u27a4 AND</li><li>\u27a4 Serum \u03b2hCG < 1000 IU/L AND</li><li>\u27a4 AND</li><li>\u27a4 Tubal ectopic < 35mm with no visible heartbeat AND</li><li>\u27a4 AND</li><li>\u27a4 Able to return for follow up</li><li>\u27a4 Repeat \u03b2hCG levels on days 2, 4 and 7 after the original test If \u03b2hCG levels drop \u2265 15% from the previous values, then repeat weekly till a negative result If values fall < 15%, stay the same or rise from the previous value, review the condition and consider shifting to medical/ surgical management</li><li>\u27a4 Repeat \u03b2hCG levels on days 2, 4 and 7 after the original test</li><li>\u27a4 If \u03b2hCG levels drop \u2265 15% from the previous values, then repeat weekly till a negative result</li><li>\u27a4 If values fall < 15%, stay the same or rise from the previous value, review the condition and consider shifting to medical/ surgical management</li><li>\u27a4 Ref: page no 378, William\u2019s Obstetrics 25 th edition, https://www.nice.org.uk/guidance/ng126</li><li>\u27a4 Ref: page no 378, William\u2019s Obstetrics 25 th edition, https://www.nice.org.uk/guidance/ng126</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "174cd4b0",
      "audio": ""
    },
    {
      "text": "The drug of choice for medical management of an unruptured ectopic pregnancy is?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mifepristone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Misoprostol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Potassium chloride",
          "correct": false
        }
      ],
      "correct_answer": "A. Methotrexate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/18/screenshot-2024-03-18-121206.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Methotrexate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The drug of choice for treatment of an unruptured ectopic pregnancy is Methotrexate. MOA: Inhibits dihydrofolate reductase 2 protocols: Single dose and Multidose Usually, the single dose regime is sufficient, very rarely another dose is required.</li><li>\u2022 The drug of choice for treatment of an unruptured ectopic pregnancy is Methotrexate.</li><li>\u2022 MOA: Inhibits dihydrofolate reductase</li><li>\u2022 2 protocols: Single dose and Multidose</li><li>\u2022 Usually, the single dose regime is sufficient, very rarely another dose is required.</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option B: Mifepristone: This is also known as RU486 and is a selective progesterone receptor modulator with strong anti-progestogenic action. It is commonly used in medical methods of termination of pregnancy along with misoprostol in 1 st and 2 nd trimester. Option C: Misoprostol: This is PGE1 and is a uterotonic. It induces uterine contractions and is therefore used in medical methods of termination of pregnancy, induction of labor and prophylaxis and management of atonic PPH. Option D: KCl: Ultrasound guided Intracardiac injection of Kcl is used in selective fetal termination in multifetal pregnancy reduction.</li><li>\u2022 Option B: Mifepristone: This is also known as RU486 and is a selective progesterone receptor modulator with strong anti-progestogenic action. It is commonly used in medical methods of termination of pregnancy along with misoprostol in 1 st and 2 nd trimester.</li><li>\u2022 Option B:</li><li>\u2022 Option C: Misoprostol: This is PGE1 and is a uterotonic. It induces uterine contractions and is therefore used in medical methods of termination of pregnancy, induction of labor and prophylaxis and management of atonic PPH.</li><li>\u2022 Option C:</li><li>\u2022 Option D: KCl: Ultrasound guided Intracardiac injection of Kcl is used in selective fetal termination in multifetal pregnancy reduction.</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The drug of choice for treatment of an unruptured ectopic pregnancy is Methotrexate. MOA: Inhibits dihydrofolate reductase 2 protocols: Single dose and Multidose Usually, the single dose regime is sufficient, very rarely another dose is required. 2 regimes:</li><li>\u27a4 The drug of choice for treatment of an unruptured ectopic pregnancy is Methotrexate.</li><li>\u27a4 MOA: Inhibits dihydrofolate reductase</li><li>\u27a4 2 protocols: Single dose and Multidose</li><li>\u27a4 Usually, the single dose regime is sufficient, very rarely another dose is required.</li><li>\u27a4 2 regimes:</li><li>\u27a4 Ref: Page no 377, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 377, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bd3b27c5",
      "audio": ""
    },
    {
      "text": "The preferred treatment in heterotopic pregnancy with a viable intra-uterine pregnancy with an unruptured ectopic pregnancy is?",
      "options": [
        {
          "label": "A",
          "text": "Expectant",
          "correct": false
        },
        {
          "label": "B",
          "text": "Medical",
          "correct": false
        },
        {
          "label": "C",
          "text": "Surgical",
          "correct": true
        },
        {
          "label": "D",
          "text": "Medical + Surgical",
          "correct": false
        }
      ],
      "correct_answer": "C. Surgical",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Surgical</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Incidence of heterotopic pregnancy: increasing due to ART Treatment of choice: Surgical i.e. laparoscopic salpingectomy/ salpingostomy Medical management with methotrexate is contra-indicated as it will kill the intrauterine pregnancy also</li><li>\u2022 Incidence of heterotopic pregnancy: increasing due to ART</li><li>\u2022 Treatment of choice: Surgical i.e. laparoscopic salpingectomy/ salpingostomy</li><li>\u2022 Medical management with methotrexate is contra-indicated as it will kill the intrauterine pregnancy also</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: Expectant management is not preferred in a heterotopic pregnancy Option B: Medical management: Medical management with methotrexate is contra-indicated as it will kill the intrauterine pregnancy also Option D: Medical + Surgical: There is no role of both medical and surgical management in a heterotopic pregnancy</li><li>\u2022 Option A: Expectant management is not preferred in a heterotopic pregnancy</li><li>\u2022 Option A:</li><li>\u2022 Option B: Medical management: Medical management with methotrexate is contra-indicated as it will kill the intrauterine pregnancy also</li><li>\u2022 Option B:</li><li>\u2022 Option D: Medical + Surgical: There is no role of both medical and surgical management in a heterotopic pregnancy</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A heterotopic pregnancy is an intra uterine pregnancy with an ectopic pregnancy Incidence of heterotopic pregnancy: increasing due to ART Treatment of choice: Surgical i.e. laparoscopic salpingectomy/ salpingostomy Medical management with methotrexate is contra-indicated as it will kill the intrauterine pregnancy also</li><li>\u27a4 A heterotopic pregnancy is an intra uterine pregnancy with an ectopic pregnancy</li><li>\u27a4 Incidence of heterotopic pregnancy: increasing due to ART</li><li>\u27a4 Treatment of choice: Surgical i.e. laparoscopic salpingectomy/ salpingostomy</li><li>\u27a4 Medical management with methotrexate is contra-indicated as it will kill the intrauterine pregnancy also</li><li>\u27a4 Ref: page no 142, Textbook of Obstetrics JB Sharma</li><li>\u27a4 Ref: page no 142, Textbook of Obstetrics JB Sharma</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d708a7ac",
      "audio": ""
    },
    {
      "text": "A 30-year lady presented to the gyn OPD with complaints of mild abdominal pain and spotting. She gives a history of delayed menses by about 7 days. Her UPT is faintly positive. An ultrasound with color doppler reveals the following image. What is the diagnosis and what is this sign known as?",
      "options": [
        {
          "label": "A",
          "text": "Corpus luteal cyst, Circle of fire sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "Corpus luteal cyst, Ring of fire sign.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Unruptured ectopic pregnancy, Circle of fire sign",
          "correct": false
        },
        {
          "label": "D",
          "text": "Unruptured ectopic pregnancy, Ring of fire sign",
          "correct": true
        }
      ],
      "correct_answer": "D. Unruptured ectopic pregnancy, Ring of fire sign",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/18/screenshot-2024-03-18-110437.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/18/screenshot-2024-03-18-110526.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Unruptured ectopic pregnancy, Ring of fire sign</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The patient\u2019s history is suggestive of an ectopic pregnancy (classic triad of pain, bleeding and delayed menstruation is there) The image shows the classical \u201cring of fire\u201d sign which is peri-trophoblastic vascularity. Other options: Corpus luteal cyst, Circle of fire sign: A corpus luteal cyst can present with vascularity around it on Doppler and appear like the ing of fire, not circle of fire Corpus luteal cyst, Ring of fire sign: This could be a close differential to the question given but, in the question, the classic triad of ectopic is also mentioned which will not be seen in a corpus luteal cyst Unruptured ectopic pregnancy, Circle of fire sign: The name of the sign is \u201cRing of fire\u201d</li><li>\u2022 The patient\u2019s history is suggestive of an ectopic pregnancy (classic triad of pain, bleeding and delayed menstruation is there)</li><li>\u2022 The image shows the classical \u201cring of fire\u201d sign which is peri-trophoblastic vascularity.</li><li>\u2022 Other options: Corpus luteal cyst, Circle of fire sign: A corpus luteal cyst can present with vascularity around it on Doppler and appear like the ing of fire, not circle of fire Corpus luteal cyst, Ring of fire sign: This could be a close differential to the question given but, in the question, the classic triad of ectopic is also mentioned which will not be seen in a corpus luteal cyst Unruptured ectopic pregnancy, Circle of fire sign: The name of the sign is \u201cRing of fire\u201d</li><li>\u2022 Other options:</li><li>\u2022 Corpus luteal cyst, Circle of fire sign: A corpus luteal cyst can present with vascularity around it on Doppler and appear like the ing of fire, not circle of fire Corpus luteal cyst, Ring of fire sign: This could be a close differential to the question given but, in the question, the classic triad of ectopic is also mentioned which will not be seen in a corpus luteal cyst Unruptured ectopic pregnancy, Circle of fire sign: The name of the sign is \u201cRing of fire\u201d</li><li>\u2022 Corpus luteal cyst, Circle of fire sign: A corpus luteal cyst can present with vascularity around it on Doppler and appear like the ing of fire, not circle of fire</li><li>\u2022 Corpus luteal cyst, Ring of fire sign: This could be a close differential to the question given but, in the question, the classic triad of ectopic is also mentioned which will not be seen in a corpus luteal cyst</li><li>\u2022 Unruptured ectopic pregnancy, Circle of fire sign: The name of the sign is \u201cRing of fire\u201d</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The above image showing vascularity around a sac like structure is called the ring of fire sign and is seen in unruptured ectopic pregnancy</li><li>\u27a4 The above image showing vascularity around a sac like structure is called the ring of fire sign and is seen in unruptured ectopic pregnancy</li><li>\u27a4 Ref: page no 376, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: page no 376, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "70ab7b03",
      "audio": ""
    },
    {
      "text": "A 24-year woman in her 1 st antenatal checkup reveals to her Doctor that she had taken the 1 st dose of Hepatitis B immunization prior to conception. She now asks if she should continue with the immunization schedule or not. What is the correct response?",
      "options": [
        {
          "label": "A",
          "text": "Continue with the scheduled immunization schedule.",
          "correct": true
        },
        {
          "label": "B",
          "text": "Delay the completion of immunization till after delivery",
          "correct": false
        },
        {
          "label": "C",
          "text": "Terminate the pregnancy and continue the immunization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Delay the immunization till after 20 weeks as organogenesis will be complete by then.",
          "correct": false
        }
      ],
      "correct_answer": "A. Continue with the scheduled immunization schedule.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Continue with the scheduled immunization schedule</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Hepatitis B vaccination is safe in pregnancy and the immunization schedule can be continued if the patient becomes pregnant.</li><li>\u2022 Hepatitis B vaccination is safe in pregnancy and the immunization schedule can be continued if the patient becomes pregnant.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hepatitis B immunization in pregnancy: Indicated in:</li><li>\u27a4 Those women completing their immunization schedule which was started pre conception High risk groups \u2013 Household contacts, partners are positive, multiple sexual partners, chronic liver disease, HIV +ve Dose: 0.5 ml IM at 0, 1, 6 months</li><li>\u27a4 Those women completing their immunization schedule which was started pre conception</li><li>\u27a4 High risk groups \u2013 Household contacts, partners are positive, multiple sexual partners, chronic liver disease, HIV +ve</li><li>\u27a4 Dose: 0.5 ml IM at 0, 1, 6 months</li><li>\u27a4 Ref: Page No 172 William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 172 William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0acae699",
      "audio": ""
    },
    {
      "text": "What is the preferred schedule of immunization in pregnancy regarding tetanus as per the ministry of health and family welfare?",
      "options": [
        {
          "label": "A",
          "text": "Inj Td: 1 st dose: early in pregnancy, 2 nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inj TT 1 st dose early in pregnancy, 2 nd dose after 4 weeks and booster if received 2 TT doses in a pregnancy within the last 3 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inj Tdap 1 st dose in the 2 nd trimester and 2 nd dose in the 3 rd trimester",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inj TT or Td 1 st dose in early pregnancy and 2 nd dose after 4 weeks.",
          "correct": false
        }
      ],
      "correct_answer": "A. Inj Td: 1 st dose: early in pregnancy, 2 nd dose: After 4 weeks; booster: if received 2 Td doses in a pregnancy within the last 3 years",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Inj Td: 1stdose: early in pregnancy, 2nddose: After 4 weeks; booster:\u00a0 if received 2 Td doses in a pregnancy within the last 3 years</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u2022 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u2022 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 TT, Td or Tdap</li><li>\u2022 Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 Td has replaced TT (as per MOHFW)</li><li>\u2022 1 st dose: early in pregnancy</li><li>\u2022 2 nd dose: After 4 weeks</li><li>\u2022 Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u2022 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u27a4 Vaccines given in pregnancy as per Ministry of Health and Family Welfare</li><li>\u27a4 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 TT, Td or Tdap Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 TT, Td or Tdap</li><li>\u27a4 Td has replaced TT (as per MOHFW) 1 st dose: early in pregnancy 2 nd dose: After 4 weeks Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 Td has replaced TT (as per MOHFW)</li><li>\u27a4 1 st dose: early in pregnancy</li><li>\u27a4 2 nd dose: After 4 weeks</li><li>\u27a4 Booster:  if received 2 Td doses in a pregnancy within the last 3 years</li><li>\u27a4 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li><li>\u27a4 **As per ACOG Committee Guidelines 2017, Tdap: One dose of Td replaced with Tdap preferably given between 27-36 weeks of gestation</li><li>\u27a4 Ref : https://www.fogsi.org/wp-content/uploads/2015/11/vaccination_women.pdf</li><li>\u27a4 Ref :</li><li>\u27a4 https://www.fogsi.org/wp-content/uploads/2015/11/vaccination_women.pdf</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f02d6de6",
      "audio": ""
    },
    {
      "text": "A 32-year woman who is planning to conceive visits her doctor for a pre conceptional visit. The Doctor asks her if she has been immunized against Rubella. She is not sure so she is advised to get a IgG rubella done which is positive. What is the next best step?",
      "options": [
        {
          "label": "A",
          "text": "Give the Rubella vaccine.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Advise her not to conceive for the next 3 months.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Advise her not to conceive for the next 1 month.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tell her she can safely conceive.",
          "correct": true
        }
      ],
      "correct_answer": "D. Tell her she can safely conceive.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Tell her she can safely conceive</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 A positive IgG rubella means that she is immunized against rubella She does not require any vaccination and can safely plan conception If she was IgG rubella negative, then she is susceptible to rubella in pregnancy and should be advised rubella vaccination As it is a live vaccine, she should not conceive for at least 1 month following vaccination</li><li>\u2022 A positive IgG rubella means that she is immunized against rubella</li><li>\u2022 She does not require any vaccination and can safely plan conception</li><li>\u2022 If she was IgG rubella negative, then she is susceptible to rubella in pregnancy and should be advised rubella vaccination</li><li>\u2022 As it is a live vaccine, she should not conceive for at least 1 month following vaccination</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A positive IgG rubella indicates the patient is immune and does not require pre-conceptional rubella vaccination</li><li>\u27a4 A positive IgG rubella indicates the patient is immune and does not require pre-conceptional rubella vaccination</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li><li>\u27a4 Ref: Page no 499, Williams Obstetrics 26 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "950936d7",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman is scheduled for her prenatal visit. She inquires about vaccines recommended during pregnancy. Which vaccine is generally considered safe and recommended for pregnant women to protect both the mother and the newborn?",
      "options": [
        {
          "label": "A",
          "text": "Mumps, Measles, and Rubella (MMR) vaccine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Human papillomavirus (HPV) vaccine",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above",
          "correct": false
        }
      ],
      "correct_answer": "B. Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The Tdap vaccine is generally considered safe and recommended for pregnant women, typically between 27-36 weeks of gestation. This vaccine helps protect the mother from tetanus, diphtheria, and pertussis (whooping cough), and it also provides passive immunity to the newborn, as pertussis can be severe in infants.</li><li>\u2022 The Tdap vaccine is generally considered safe and recommended for pregnant women, typically between 27-36 weeks of gestation. This vaccine helps protect the mother from tetanus, diphtheria, and pertussis (whooping cough), and it also provides passive immunity to the newborn, as pertussis can be severe in infants.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option C: The HPV vaccine is not typically given during pregnancy. It is usually recommended for females before becoming pregnant to prevent HPV infection, which can lead to cervical cancer. If a woman becomes pregnant during the HPV vaccination series, it is generally recommended to complete the series after pregnancy, as there is limited data on its use during pregnancy. Option A: The MMR vaccine is not typically recommended during pregnancy because it is a live attenuated vaccine, meaning it contains weakened forms of the viruses. Live vaccines are generally contraindicated during pregnancy due to potential risks to the developing fetus.</li><li>\u2022 Option C: The HPV vaccine is not typically given during pregnancy. It is usually recommended for females before becoming pregnant to prevent HPV infection, which can lead to cervical cancer. If a woman becomes pregnant during the HPV vaccination series, it is generally recommended to complete the series after pregnancy, as there is limited data on its use during pregnancy.</li><li>\u2022 Option C:</li><li>\u2022 Option A: The MMR vaccine is not typically recommended during pregnancy because it is a live attenuated vaccine, meaning it contains weakened forms of the viruses. Live vaccines are generally contraindicated during pregnancy due to potential risks to the developing fetus.</li><li>\u2022 Option A:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Tdap is safe in pregnancy; given between 27-36 weeks; can replace the 2 nd dose of Td; provides immunity to mother and newborn against tetanus, diphtheria, and pertussis.</li><li>\u27a4 Tdap is safe in pregnancy; given between 27-36 weeks; can replace the 2 nd dose of Td; provides immunity to mother and newborn against tetanus, diphtheria, and pertussis.</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "922814da",
      "audio": ""
    },
    {
      "text": "A 25-year-old pregnant woman, who is a healthcare worker, asks about receiving the hepatitis B vaccine during pregnancy. What is the most appropriate recommendation regarding hepatitis B vaccination for pregnant healthcare workers?",
      "options": [
        {
          "label": "A",
          "text": "Administer the hepatitis B vaccine during pregnancy.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Delay hepatitis B vaccination until after delivery.",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hepatitis B vaccination is not necessary for pregnant healthcare workers.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Recommend hepatitis B vaccination after assessing the patient's risk factors.",
          "correct": true
        }
      ],
      "correct_answer": "D. Recommend hepatitis B vaccination after assessing the patient's risk factors.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Recommend hepatitis B vaccination after assessing the patient's risk factors.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Hepatitis B vaccination is recommended for pregnant healthcare workers, but the timing should be individualized. Pregnant healthcare workers should be assessed for their risk of exposure to hepatitis B and, if indicated, should receive the vaccine after careful consideration of the potential benefits and risks.</li><li>\u2022 Hepatitis B vaccination is recommended for pregnant healthcare workers, but the timing should be individualized. Pregnant healthcare workers should be assessed for their risk of exposure to hepatitis B and, if indicated, should receive the vaccine after careful consideration of the potential benefits and risks.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hepatitis B vaccine is safe in pregnancy and is recommended to high risk groups</li><li>\u27a4 Hepatitis B vaccine is safe in pregnancy and is recommended to high risk groups</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 172, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "45e703e3",
      "audio": ""
    },
    {
      "text": "All are features of a true sac except:",
      "options": [
        {
          "label": "A",
          "text": "Intra-decidual sign is negative",
          "correct": true
        },
        {
          "label": "B",
          "text": "It is eccentric in position",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peripheral vascularity is seen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Yolk sac is seen at 5.5 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. Intra-decidual sign is negative",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-172027.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Intra-decidual sign is negative</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Intra-decidual sign is seen in a true sac</li><li>\u2022 Intra-decidual sign is seen in a true sac</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: A true sac is eccentric in position Option C: Peripheral vascularity is seen in a true gestational sac Option D: Yolk sac is seen at 5.5 weeks in a TVS</li><li>\u2022 Option B: A true sac is eccentric in position</li><li>\u2022 Option B:</li><li>\u2022 Option C: Peripheral vascularity is seen in a true gestational sac</li><li>\u2022 Option C:</li><li>\u2022 Option D: Yolk sac is seen at 5.5 weeks in a TVS</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page No 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dabe56c0",
      "audio": ""
    },
    {
      "text": "Double Decidual Sac sign is seen in:",
      "options": [
        {
          "label": "A",
          "text": "Early intra-uterine pregnancy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Intra-uterine pseudo gestational sac",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tubal ectopic pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Molar pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "A. Early intra-uterine pregnancy",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-329.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Early Intra \u2013 uterine pregnancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Double decidual sac sign is seen in an intra-uterine pregnancy.</li><li>\u2022 Other Options</li><li>\u2022 Other Options</li><li>\u2022 Option B: An intra-uterine pseudo sac is seen usually in an ectopic pregnancy, It is fluid collection in the uterus Option C: Tubal ectopic pregnancy: in this a double decidual sac sign wont be seen. USG signs of a tubal pregnancy include bagel sign, blob sign and ring of fire sign Option D: In Molar pregnancy , the characteristic sign seen is the snowstorm appearance</li><li>\u2022 Option B: An intra-uterine pseudo sac is seen usually in an ectopic pregnancy, It is fluid collection in the uterus</li><li>\u2022 Option B:</li><li>\u2022 intra-uterine pseudo sac</li><li>\u2022 Option C: Tubal ectopic pregnancy: in this a double decidual sac sign wont be seen. USG signs of a tubal pregnancy include bagel sign, blob sign and ring of fire sign</li><li>\u2022 Option C:</li><li>\u2022 Tubal ectopic pregnancy:</li><li>\u2022 Option D: In Molar pregnancy , the characteristic sign seen is the snowstorm appearance</li><li>\u2022 Option D:</li><li>\u2022 Molar pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Double Decidual sac sign:</li><li>\u27a4 Double Decidual sac sign:</li><li>\u27a4 Is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP) Especially useful when the yolk sac or embryo is still not visualized. It consists of the decidua parietalis (lining the uterine cavity) and decidua capsularis (lining the gestational sac) It is seen as two concentric rings surrounding an anechoic gestational sac. Where the two adhere is the decidua basalis, and is the site of future placental formation.</li><li>\u27a4 Is a useful feature on early pregnancy ultrasound to confirm an early intrauterine pregnancy (IUP)</li><li>\u27a4 Especially useful when the yolk sac or embryo is still not visualized.</li><li>\u27a4 It consists of the decidua parietalis (lining the uterine cavity) and decidua capsularis (lining the gestational sac)</li><li>\u27a4 It is seen as two concentric rings surrounding an anechoic gestational sac.</li><li>\u27a4 Where the two adhere is the decidua basalis, and is the site of future placental formation.</li><li>\u27a4 Another sign of an intra-uterine pregnancy is the intra-decidual sign.</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e5c5027",
      "audio": ""
    },
    {
      "text": "Identify the condition as shown in the image below:",
      "options": [
        {
          "label": "A",
          "text": "Anterior Placenta Previa (Partial)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Posterior Placenta Previa (Partial)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ant Placenta Previa (Marginal)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Posterior placenta previa (Marginal)",
          "correct": false
        }
      ],
      "correct_answer": "B. Posterior Placenta Previa (Partial)",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/untitled-330_zDnYB0n.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/08/aph-2.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Posterior Placenta Previa \u2013 Partial</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This is an Obstetric ultrasound showing the lower uterine segment with the bladder anteriorly. The cervix is seen and the placenta is seen posteriorly (as it is opposite to the bladder). It is seen to partially cover the os. So, this is Post placenta previa (partial).</li><li>\u2022 This is an Obstetric ultrasound showing the lower uterine segment with the bladder anteriorly. The cervix is seen and the placenta is seen posteriorly (as it is opposite to the bladder). It is seen to partially cover the os. So, this is Post placenta previa (partial).</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Placenta previa is classified as follows:</li><li>\u27a4 Placenta previa is classified as follows:</li><li>\u27a4 Type 1 ---Mild degree ----- Type 2     Type 3--- Major degree ----- Type 4</li><li>\u27a4 Type 1: Low lying:  implantation in lower uterine segment but not touching the os.</li><li>\u27a4 Type 2: Marginal: placenta is at the edge of the os but not covering it</li><li>\u27a4 Type 3: Partial Placenta Previa: Placenta partially covering the internal os.</li><li>\u27a4 Type 4: Complete Placenta Previa: Placenta completely covering the internal os.</li><li>\u27a4 Placenta previa can also be classified on USG as (Newer system) True placenta previa : the placenta covers the internal os either partially or completely Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 Placenta previa can also be classified on USG as (Newer system) True placenta previa : the placenta covers the internal os either partially or completely Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 True placenta previa : the placenta covers the internal os either partially or completely Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 True placenta previa : the placenta covers the internal os either partially or completely</li><li>\u27a4 Low lying placenta:  placenta is implanted in the lower uterine segment such that the edge does not reach the os  but remains  outside a 2 cm wide  perimeter around the os.</li><li>\u27a4 Ref: Page 774, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page 774, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4e0dc875",
      "audio": ""
    },
    {
      "text": "A 34-year primi presents at 8 weeks pregnancy, The ultrasound shows an anembryonic pregnancy. An anembryonic pregnancy is when, on ultrasound, the embryo is not seen at a Mean Sac Diameter (MSD) of:",
      "options": [
        {
          "label": "A",
          "text": "\u2265 20 mm",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2265 25 mm",
          "correct": true
        },
        {
          "label": "C",
          "text": "\u2265 30 mm",
          "correct": false
        },
        {
          "label": "D",
          "text": "\u2265 35 mm",
          "correct": false
        }
      ],
      "correct_answer": "B. \u2265 25 mm",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u2265 25mm</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u2022 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy</li><li>\u2022 Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u27a4 Absence of an embryo at a MSD \u2265 25 mm \u2013 anembryonic pregnancy</li><li>\u27a4 Absence of Cardiac activity at a CRL \u2265 7 mm \u2013 non-viable pregnancy</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "68a7b734",
      "audio": ""
    },
    {
      "text": "The best measurement for estimating gestational age on ultrasound is:",
      "options": [
        {
          "label": "A",
          "text": "Biparietal diameter",
          "correct": false
        },
        {
          "label": "B",
          "text": "Crown \u2013 Rump length",
          "correct": true
        },
        {
          "label": "C",
          "text": "Head circumference",
          "correct": false
        },
        {
          "label": "D",
          "text": "Femur length",
          "correct": false
        }
      ],
      "correct_answer": "B. Crown \u2013 Rump length",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Crown-Rump Length</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 CRL: This is the Crown-Rump Length and is the most accurate method to establish and confirm the gestational age</li><li>\u2022 CRL: This is the Crown-Rump Length and is the most accurate method to establish and confirm the gestational age</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A: Biparietal diameter (BPD): The BPD is a measurement of the fetus done after 14 weeks. It is the most accurate estimation of gestational age after 14 weeks. Option C: Head circumference: The HC is a measurement done after 14 weeks Option D : Femur length is also a fetal biometric measurement done after 14 weeks.</li><li>\u2022 Option A: Biparietal diameter (BPD): The BPD is a measurement of the fetus done after 14 weeks. It is the most accurate estimation of gestational age after 14 weeks.</li><li>\u2022 Option A:</li><li>\u2022 Biparietal diameter (BPD):</li><li>\u2022 Option C: Head circumference: The HC is a measurement done after 14 weeks</li><li>\u2022 Option C:</li><li>\u2022 Head circumference:</li><li>\u2022 Option D : Femur length is also a fetal biometric measurement done after 14 weeks.</li><li>\u2022 Option D</li><li>\u2022 Femur length</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 About Crown Rump Length (CRL)</li><li>\u27a4 Most accurate method to establish/ confirm gestational age It is measured in the mid \u2013 sagittal plane Embryo in neutral position Till 13 weeks: accuracy of 5 \u2013 7 days In the 2 nd trimester the best parameter to estimate gestational age in:  BPD If dolichocephaly/ brachycephaly; HC better Abdominal Circumference (AC): greatest variation</li><li>\u27a4 Most accurate method to establish/ confirm gestational age</li><li>\u27a4 It is measured in the mid \u2013 sagittal plane</li><li>\u27a4 Embryo in neutral position</li><li>\u27a4 Till 13 weeks: accuracy of 5 \u2013 7 days</li><li>\u27a4 In the 2 nd trimester the best parameter to estimate gestational age in:  BPD</li><li>\u27a4 If dolichocephaly/ brachycephaly; HC better</li><li>\u27a4 Abdominal Circumference (AC): greatest variation</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 159, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5c910805",
      "audio": ""
    },
    {
      "text": "A 30-year-old pregnant woman in her second trimester presents for a routine prenatal ultrasound. What is the primary purpose of this mid-pregnancy ultrasound?",
      "options": [
        {
          "label": "A",
          "text": "To assess for neural tube defects",
          "correct": false
        },
        {
          "label": "B",
          "text": "To evaluate fetal growth and anatomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "To estimate amniotic fluid volume",
          "correct": false
        },
        {
          "label": "D",
          "text": "To check for placental abnormalities",
          "correct": false
        }
      ],
      "correct_answer": "B. To evaluate fetal growth and anatomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. To evaluate fetal growth and anatomy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The primary purpose of a mid-pregnancy ultrasound (typically performed between 18-22 weeks) is to evaluate fetal growth and anatomy, including assessing the development of various organs and structures in the fetus. This scan may also be referred to as anomaly scan/ malformation scan/ Targeted imaging for fetal anomaly (TIFFA scan)</li><li>\u2022 The primary purpose of a mid-pregnancy ultrasound (typically performed between 18-22 weeks) is to evaluate fetal growth and anatomy, including assessing the development of various organs and structures in the fetus. This scan may also be referred to as anomaly scan/ malformation scan/ Targeted imaging for fetal anomaly (TIFFA scan)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective: Routine ultrasounds done in pregnancy include</li><li>\u27a4 1 st trimester (6-10 weeks): For confirmation of pregnancy, excluding ectopic pregnancy, number of fetuses, viability, adnexal lesions 11-14 weeks: Level 1 scan: For Down syndrome screening and uterine artery doppler for preeclampsia screening 18-22 weeks: TIFFA scan (Targeted imaging for fetal anomaly) > 28 weeks: Fetal growth and well being, placental localization, amniotic fluid volume, confirming presentation.</li><li>\u27a4 1 st trimester (6-10 weeks): For confirmation of pregnancy, excluding ectopic pregnancy, number of fetuses, viability, adnexal lesions</li><li>\u27a4 1 st trimester (6-10 weeks):</li><li>\u27a4 11-14 weeks: Level 1 scan: For Down syndrome screening and uterine artery doppler for preeclampsia screening</li><li>\u27a4 11-14 weeks:</li><li>\u27a4 18-22 weeks: TIFFA scan (Targeted imaging for fetal anomaly)</li><li>\u27a4 18-22 weeks:</li><li>\u27a4 > 28 weeks: Fetal growth and well being, placental localization, amniotic fluid volume, confirming presentation.</li><li>\u27a4 > 28 weeks:</li></ul>\n<p><strong>References:</strong></p><ul><li>\u21b3 Reference: Williams textbook of Obstetrics 25 th edition page 187</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "060444d2",
      "audio": ""
    },
    {
      "text": "A 32-year-old pregnant woman is prescribed a medication for her chronic medical condition. She asks if this medication is a teratogen. The physician explains that this medication can potentially cause limb and ear malformations if taken during pregnancy. Which medication is the physician most likely referring to?",
      "options": [
        {
          "label": "A",
          "text": "Penicillin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Prednisone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Valproic acid",
          "correct": true
        },
        {
          "label": "D",
          "text": "Omeprazole",
          "correct": false
        }
      ],
      "correct_answer": "C. Valproic acid",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Valproic acid</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A, B and D: (penicillin, prednisone, omeprazole) are generally considered safer choices during pregnancy.</li><li>\u2022 Option A, B and D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Valproic acid, an antiepileptic medication, is associated with an increased risk of limb and ear malformations when taken during pregnancy. It is considered a teratogen, and alternative medications should be considered for pregnant women with epilepsy.</li><li>\u27a4 Valproic acid, an antiepileptic medication, is associated with an increased risk of limb and ear malformations when taken during pregnancy.</li><li>\u27a4 It is considered a teratogen, and alternative medications should be considered for pregnant women with epilepsy.</li><li>\u27a4 Ref: Page no 240, William\u2019s Obstetrics 25th edition</li><li>\u27a4 Ref: Page no 240, William\u2019s Obstetrics 25th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29f9fb56",
      "audio": ""
    },
    {
      "text": "Lithium in pregnancy is associated with an increased incidence of?",
      "options": [
        {
          "label": "A",
          "text": "Orofacial clefting",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ebstein anomaly",
          "correct": true
        },
        {
          "label": "C",
          "text": "Neurobehavioral abnormalities",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cardiovascular anomalies",
          "correct": false
        }
      ],
      "correct_answer": "B. Ebstein anomaly",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Ebstein anomaly</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Lithium has been associated with Ebstein anomaly</li><li>\u2022 Lithium has been associated with Ebstein anomaly</li><li>\u2022 This is an otherwise rare anomaly but has a 3% risk in women on Lithium. Fetal ECHO is indicated in women on Lithium</li><li>\u2022 This is an otherwise rare anomaly but has a 3% risk in women on Lithium.</li><li>\u2022 Fetal ECHO is indicated in women on Lithium</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Lithium has been associated with Ebstein anomaly</li><li>\u27a4 Lithium has been associated with Ebstein anomaly</li><li>\u27a4 This is an otherwise rare anomaly but has a 3% risk in women on Lithium. Fetal ECHO is indicated in women on Lithium</li><li>\u27a4 This is an otherwise rare anomaly but has a 3% risk in women on Lithium.</li><li>\u27a4 Fetal ECHO is indicated in women on Lithium</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 245, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb4fac9b",
      "audio": ""
    },
    {
      "text": "All the following methods can be used to calculate the EDD except:",
      "options": [
        {
          "label": "A",
          "text": "Adding 9 months and 7 days to the LMP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Adding 38 weeks to the LMP",
          "correct": true
        },
        {
          "label": "C",
          "text": "Adding 280 days to the LMP",
          "correct": false
        },
        {
          "label": "D",
          "text": "Subtracting 3 months and adding 7 days to the LMP",
          "correct": false
        }
      ],
      "correct_answer": "B. Adding 38 weeks to the LMP",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Calculating the EDD:</li><li>\u2022 Calculating the EDD:</li><li>\u2022 Normal duration of pregnancy: 280 days (40 weeks); hence Option B is incorrect. To arrive at the EDD, we add 280 days or 40 weeks to the LMP.</li><li>\u2022 Normal duration of pregnancy: 280 days (40 weeks); hence Option B is incorrect. To arrive at the EDD, we add 280 days or 40 weeks to the LMP.</li><li>\u2022 Other Options:</li><li>\u2022 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u2022 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u2022 Naegele\u2019s formula</li><li>\u2022 Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u2022 Add 9 months + 7 days</li><li>\u2022 Subtract 3 months and add 7 days</li><li>\u2022 For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day) Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer Remember the EDD falls at 40 weeks (280 days) from the LMP Dating the pregnancy: If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 Calculating the EDD: Naegele\u2019s formula . To the LMP (1 st day of the last menstrual day) Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Naegele\u2019s formula</li><li>\u27a4 Add 9 months + 7 days Subtract 3 months and add 7 days For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Add 9 months + 7 days</li><li>\u27a4 Subtract 3 months and add 7 days</li><li>\u27a4 For IVF Pregnancies: add 38 weeks to the date of the embryo transfer</li><li>\u27a4 Remember the EDD falls at 40 weeks (280 days) from the LMP</li><li>\u27a4 Dating the pregnancy: If discrepancy in dates/ unsure of LMP; the best way to determine the dating is by ULTRASOUND 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 Dating the pregnancy:</li><li>\u27a4 1st trimester CRL: most accurate (till 14 weeks) BPD in the 2nd trimester</li><li>\u27a4 1st trimester CRL: most accurate (till 14 weeks)</li><li>\u27a4 BPD in the 2nd trimester</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page no 168, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b5212064",
      "audio": ""
    },
    {
      "text": "A 25-year Primi gravida is at 24 weeks pregnancy. Her pre-pregnancy BMI was 22. She is concerned she hasn\u2019t been gaining enough weight during pregnancy. What should her ideal weight gain (kg)/ week be?",
      "options": [
        {
          "label": "A",
          "text": "0.5 kg / week",
          "correct": false
        },
        {
          "label": "B",
          "text": "0.4 kg / week",
          "correct": true
        },
        {
          "label": "C",
          "text": "0.3 kg / week",
          "correct": false
        },
        {
          "label": "D",
          "text": "0.2 kg / week",
          "correct": false
        }
      ],
      "correct_answer": "B. 0.4 kg / week",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/10/screenshot-2024-01-10-114427.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 In a woman with normal BMI, the ideal weight gain is 0.4kg/ week in the 2 nd and 3 rd trimester</li><li>\u2022 In a woman with normal BMI, the ideal weight gain is 0.4kg/ week in the 2 nd and 3 rd trimester</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ideal weight gain in pregnancy</li><li>\u27a4 Ref: Page no 170, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page no 170, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2bb40908",
      "audio": ""
    },
    {
      "text": "A 23-year primigravida is diagnosed to have Down syndrome of her fetus at 18 weeks. If a triple test was done, what would have been the report?",
      "options": [
        {
          "label": "A",
          "text": "High HCG, low ue3, low AFP",
          "correct": true
        },
        {
          "label": "B",
          "text": "Low HCG, high ue3, high AFP",
          "correct": false
        },
        {
          "label": "C",
          "text": "High HCG, high ue3, low AFP",
          "correct": false
        },
        {
          "label": "D",
          "text": "Low HCG, low uE3, high AFP",
          "correct": false
        }
      ],
      "correct_answer": "A. High HCG, low ue3, low AFP",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-185442_TtgJ5L7.jpg"
      ],
      "explanation": "<p><strong>Ans. A) High HCG, low ue3, low AFP</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The Triple and Quadruple test are done between 15 \u2013 21 weeks.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u2022 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u2022 *Easy to remember: B for B ig; so in Down\u2019s syndrome; B eta hCG and Inhi B in A: B ig/ Increased</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li><li>\u2022 B</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Triple and Quadruple test are 2 nd trimester biochemical screening tests for Down Syndrome and are done between 15 \u2013 21 weeks.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein. Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Components of Triple test are: Free \u03b2 hCG, unconjugated Estriol (uE3) and Maternal Serum \u03b1-fetoprotein.</li><li>\u27a4 Components of the Quadruple test are: Free \u03b2 hCG, unconjugated Estriol (uE3), Maternal Serum \u03b1-fetoprotein. And Inhibin A.</li><li>\u27a4 Page no 284, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Page no 284, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d4072b17",
      "audio": ""
    },
    {
      "text": "Which of the following is done for screening of Down\u2019s syndrome in the first trimester?",
      "options": [
        {
          "label": "A",
          "text": "Beta HCG and PAPP-A",
          "correct": true
        },
        {
          "label": "B",
          "text": "Unconjugated estradiol and PAPPA",
          "correct": false
        },
        {
          "label": "C",
          "text": "AFP and Inhibin A",
          "correct": false
        },
        {
          "label": "D",
          "text": "AFP and Beta HCG",
          "correct": false
        }
      ],
      "correct_answer": "A. Beta HCG and PAPP-A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/screenshot-2024-01-09-185858.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Beta HCG and PAPP-A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 1 st trimester (11-14 weeks) serum analytes for Down\u2019s syndrome screening are: Beta hCG and PAPP-A.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 1 st trimester (11-14 weeks) serum analytes for Down\u2019s syndrome screening are: Beta hCG and PAPP-A. This is called the Dual marker/ Double marker</li><li>\u27a4 1 st trimester (11-14 weeks) serum analytes for Down\u2019s syndrome screening are: Beta hCG and PAPP-A.</li><li>\u27a4 This is called the Dual marker/ Double marker</li><li>\u27a4 Page no 281, William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Page no 281, William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8d898b2",
      "audio": ""
    },
    {
      "text": "Non-Invasive Prenatal Testing (NIPT) is?",
      "options": [
        {
          "label": "A",
          "text": "Amniocentesis for evaluation of fetal chromosomal anomalies",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pre-conceptional gene testing of an ova",
          "correct": false
        },
        {
          "label": "C",
          "text": "Maternal serum for evaluation of Down syndrome",
          "correct": true
        },
        {
          "label": "D",
          "text": "Testing of maternal tissue",
          "correct": false
        }
      ],
      "correct_answer": "C. Maternal serum for evaluation of Down syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Maternal serum for evaluation of Down syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 NIPT or cell free DNA screening: Salient features:</li><li>\u2022 Introduced in 2011 It is a screening test (NOT DIAGNOSTIC) In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation Identification of DNA fragments that are derived primarily from apoptotic trophoblasts. Done after 9 \u2013 10 weeks Results in 7 \u2013 10 days 99% Detection rate for Down syndrome Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Introduced in 2011</li><li>\u2022 It is a screening test (NOT DIAGNOSTIC)</li><li>\u2022 In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u2022 Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u2022 Age \u2265 35 y</li><li>\u2022 A positive 1 st /2 nd trimester analyte-based screening test</li><li>\u2022 USG with minor (soft) aneuploidy marker</li><li>\u2022 Prior pregnancy with autosomal trisomy</li><li>\u2022 Known carriage of a balanced translocation</li><li>\u2022 Identification of DNA fragments that are derived primarily from apoptotic trophoblasts.</li><li>\u2022 Done after 9 \u2013 10 weeks</li><li>\u2022 Results in 7 \u2013 10 days</li><li>\u2022 99% Detection rate for Down syndrome</li><li>\u2022 Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Cost</li><li>\u2022 The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Placental mosaicism</li><li>\u2022 Early demise of an aneuploid twin</li><li>\u2022 Maternal mosaicism</li><li>\u2022 Occult maternal malignancy</li><li>\u2022 Limited role in multiple pregnancy</li><li>\u2022 In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. Amniocentesis for evaluation of fetal chromosomal anomalies: Amniocentesis is a diagnostic method for fetal chromosomal anomalies. It is preferably done after 15 weeks of gestation. Option B. Preconceptional gene testing for an ova: There is no such thing; however preimplantation genetic testing can be done of an embryo in IVF, prior to embryo transfer. Option D. Testing of maternal tissue: This is not a test for screening or diagnosis of Down syndrome</li><li>\u2022 Option A. Amniocentesis for evaluation of fetal chromosomal anomalies: Amniocentesis is a diagnostic method for fetal chromosomal anomalies. It is preferably done after 15 weeks of gestation.</li><li>\u2022 Option A.</li><li>\u2022 Option B. Preconceptional gene testing for an ova: There is no such thing; however preimplantation genetic testing can be done of an embryo in IVF, prior to embryo transfer.</li><li>\u2022 Option B.</li><li>\u2022 Option D. Testing of maternal tissue: This is not a test for screening or diagnosis of Down syndrome</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 NIPT or cell free DNA screening: Salient features:</li><li>\u27a4 Introduced in 2011 It is a screening test (NOT DIAGNOSTIC) In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation Identification of DNA fragments that are derived primarily from apoptotic trophoblasts. Done after 9 \u2013 10 weeks Results in 7 \u2013 10 days 99% Detection rate for Down syndrome Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Introduced in 2011</li><li>\u27a4 It is a screening test (NOT DIAGNOSTIC)</li><li>\u27a4 In 2020 (Oct), ACOG guidelines state that along with serum analytes and NT, cell free DNA can be offered to all women as the initial screening modality for Down syndrome. Prior to this the indications were Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u27a4 Age \u2265 35 y A positive 1 st /2 nd trimester analyte-based screening test USG with minor (soft) aneuploidy marker Prior pregnancy with autosomal trisomy Known carriage of a balanced translocation</li><li>\u27a4 Age \u2265 35 y</li><li>\u27a4 A positive 1 st /2 nd trimester analyte-based screening test</li><li>\u27a4 USG with minor (soft) aneuploidy marker</li><li>\u27a4 Prior pregnancy with autosomal trisomy</li><li>\u27a4 Known carriage of a balanced translocation</li><li>\u27a4 Identification of DNA fragments that are derived primarily from apoptotic trophoblasts.</li><li>\u27a4 Done after 9 \u2013 10 weeks</li><li>\u27a4 Results in 7 \u2013 10 days</li><li>\u27a4 99% Detection rate for Down syndrome</li><li>\u27a4 Limitations: Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Cost The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy Limited role in multiple pregnancy In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Cost</li><li>\u27a4 The DNA component may not actually reflect fetal DNA and instead may reflect: Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy</li><li>\u27a4 Placental mosaicism Early demise of an aneuploid twin Maternal mosaicism Occult maternal malignancy</li><li>\u27a4 Placental mosaicism</li><li>\u27a4 Early demise of an aneuploid twin</li><li>\u27a4 Maternal mosaicism</li><li>\u27a4 Occult maternal malignancy</li><li>\u27a4 Limited role in multiple pregnancy</li><li>\u27a4 In 4 \u2013 8%: No result due to low fetal fraction of DNA</li><li>\u27a4 Ref: Page No 284, 285; William\u2019s Obstetrics, 25 th edition</li><li>\u27a4 Ref: Page No 284, 285; William\u2019s Obstetrics, 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c778cdcc",
      "audio": ""
    },
    {
      "text": "All are true regarding prenatal Down syndrome screening except?",
      "options": [
        {
          "label": "A",
          "text": "The risk of a woman carrying a Down syndrome baby is about 1 in 70 at 40 years",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ultrasound features of Down syndrome at 11 \u2013 14 weeks include increased NT and an absent nasal bone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Combined test includes an NT measurement and the dual marker",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ultrasound at 18 \u2013 20 weeks will miss about 50% of Down syndrome fetuses",
          "correct": true
        }
      ],
      "correct_answer": "D. Ultrasound at 18 \u2013 20 weeks will miss about 50% of Down syndrome fetuses",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Ultrasound at 18 \u2013 20 weeks will miss about 50% of Down syndrome fetuses</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Let\u2019s Discuss all the Options</li><li>\u2022 Let\u2019s Discuss all the Options</li><li>\u2022 Option A. The risk of Down syndrome increases with maternal age. At the age of 40y, the risk os about 1 in 70 Option B. At 11-14 weeks, ultrasound features of Down syndrome include An increased nuchal translucency An absent nasal bone Tricuspid regurgitation An abnormal flow in the ductus venosus Option C. Combined test refers to a combination of the NT and Dual marker Option D. An ultrasound at 18-20 weeks will detect upto 70% of Down syndrome babies. Hence this option is correct</li><li>\u2022 Option A. The risk of Down syndrome increases with maternal age. At the age of 40y, the risk os about 1 in 70</li><li>\u2022 Option A.</li><li>\u2022 Option B. At 11-14 weeks, ultrasound features of Down syndrome include An increased nuchal translucency An absent nasal bone Tricuspid regurgitation An abnormal flow in the ductus venosus</li><li>\u2022 Option B.</li><li>\u2022 An increased nuchal translucency An absent nasal bone Tricuspid regurgitation An abnormal flow in the ductus venosus</li><li>\u2022 An increased nuchal translucency</li><li>\u2022 An absent nasal bone</li><li>\u2022 Tricuspid regurgitation</li><li>\u2022 An abnormal flow in the ductus venosus</li><li>\u2022 Option C. Combined test refers to a combination of the NT and Dual marker</li><li>\u2022 Option C.</li><li>\u2022 Option D. An ultrasound at 18-20 weeks will detect upto 70% of Down syndrome babies. Hence this option is correct</li><li>\u2022 Option D.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Screening of Down Syndrome: Trisomy 21 (Down syndrome); is the most common non-lethal trisomy Background risk is based on age (At 25 y: 1 in 5000, 30 y: 1 in 1000, 33 y: 1 in 500, 35 y: 1 in 250, 40 y: 1 in 70, 45 y: 1 in 20) Ultrasound at 11 \u2013 14 weeks: Features of Down Syndrome include: Increased NT Absent nasal bone Abnormal flow in the Ductus venosus Tricuspid Regurgitation 1 st trimester screening for Down Syndrome includes the Dual marker and the NT. Detection rate for Down Syndrome by a 2 nd trimester ultrasound is 70%</li><li>\u27a4 Screening of Down Syndrome:</li><li>\u27a4 Trisomy 21 (Down syndrome); is the most common non-lethal trisomy</li><li>\u27a4 Background risk is based on age (At 25 y: 1 in 5000, 30 y: 1 in 1000, 33 y: 1 in 500, 35 y: 1 in 250, 40 y: 1 in 70, 45 y: 1 in 20)</li><li>\u27a4 Ultrasound at 11 \u2013 14 weeks: Features of Down Syndrome include: Increased NT Absent nasal bone Abnormal flow in the Ductus venosus Tricuspid Regurgitation</li><li>\u27a4 Increased NT Absent nasal bone Abnormal flow in the Ductus venosus Tricuspid Regurgitation</li><li>\u27a4 Increased NT</li><li>\u27a4 Absent nasal bone</li><li>\u27a4 Abnormal flow in the Ductus venosus</li><li>\u27a4 Tricuspid Regurgitation</li><li>\u27a4 1 st trimester screening for Down Syndrome includes the Dual marker and the NT.</li><li>\u27a4 Detection rate for Down Syndrome by a 2 nd trimester ultrasound is 70%</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 282, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "33661b71",
      "audio": ""
    },
    {
      "text": "The image below shows the Nuchal translucency (NT) on Ultrasound. A high NT is associated with fetal aneuploidies and poor perinatal outcome. At what gestational period is the NT measured?",
      "options": [
        {
          "label": "A",
          "text": "10 \u2013 13 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 weeks 6 days \u2013 13 weeks 6 days",
          "correct": false
        },
        {
          "label": "C",
          "text": "12 \u2013 14 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "11 weeks \u2013 13 weeks 6 days",
          "correct": true
        }
      ],
      "correct_answer": "D. 11 weeks \u2013 13 weeks 6 days",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture1_HFXaEOk.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/09/picture2_QO5PDrg.jpg"
      ],
      "explanation": "<p><strong>Ans. D) 11 weeks \u2013 13 weeks 6 days</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Nuchal Translucency (NT):</li><li>\u2022 Component of first trimester aneuploidy screening Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck. If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks)</li><li>\u2022 Component of first trimester aneuploidy screening</li><li>\u2022 Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</li><li>\u2022 If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Fetal aneuploidy</li><li>\u2022 Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u2022 Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Component of first trimester aneuploidy screening Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck. If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks) Criteria to measure the NT CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 Component of first trimester aneuploidy screening</li><li>\u27a4 Represents maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</li><li>\u27a4 If NT increased, risk for Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Fetal aneuploidy Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Fetal aneuploidy</li><li>\u27a4 Various structural anomalies: CVS, hydrops, cystic hygroma</li><li>\u27a4 Measured between 11 weeks \u2013 13 weeks 6 days (or 11- 14 weeks)</li><li>\u27a4 Criteria to measure the NT CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 CRL between 45 \u2013 84 mm Fetus in mid sagittal plane Fetus in neutral position Image must be magnified Widest space should be measured The amnion must be seen separately The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 CRL between 45 \u2013 84 mm</li><li>\u27a4 Fetus in mid sagittal plane</li><li>\u27a4 Fetus in neutral position</li><li>\u27a4 Image must be magnified</li><li>\u27a4 Widest space should be measured</li><li>\u27a4 The amnion must be seen separately</li><li>\u27a4 The \u2018+\u2019 calipers must be placed on the inner borders of the nuchal space</li><li>\u27a4 NT alone of used: 65% detection rate for Down Syndrome Combined test: NT + Dual marker (beta hCG + PAPP-A): 80% Detection rate NT > 3 mm/ > 99 th percentile: Significant</li><li>\u27a4 NT alone of used: 65% detection rate for Down Syndrome</li><li>\u27a4 Combined test: NT + Dual marker (beta hCG + PAPP-A): 80% Detection rate</li><li>\u27a4 NT > 3 mm/ > 99 th percentile: Significant</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 186, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8bc1718c",
      "audio": ""
    },
    {
      "text": "A raised uterine pulsatility index at 11-14 weeks on uterine artery doppler is a predictor for?",
      "options": [
        {
          "label": "A",
          "text": "Down Syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gestational Diabetes",
          "correct": false
        },
        {
          "label": "C",
          "text": "Placenta previa",
          "correct": false
        },
        {
          "label": "D",
          "text": "Preeclampsia",
          "correct": true
        }
      ],
      "correct_answer": "D. Preeclampsia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Preeclampsia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Uterine artery blood flow is estimated to rise from 50ml/min early in gestation to 500-700 ml/ min by term Doppler waveform of the uterine artery shows high diastolic flow velocity and markedly turbulent flow. Greater resistance to flow (High PI) and diastolic notching on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Uterine artery blood flow is estimated to rise from 50ml/min early in gestation to 500-700 ml/ min by term</li><li>\u2022 Doppler waveform of the uterine artery shows high diastolic flow velocity and markedly turbulent flow.</li><li>\u2022 Greater resistance to flow (High PI) and diastolic notching on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u2022 Preeclampsia</li><li>\u2022 Gestational HTN</li><li>\u2022 Fetal growth restriction</li><li>\u2022 Thus, option D) Pre-eclampsia is correct.</li><li>\u2022 Thus, option D) Pre-eclampsia is correct.</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 A raised uterine PI is not related to gestational diabetes, Down syndrome or placenta previa</li><li>\u2022 A raised uterine PI is not related to gestational diabetes, Down syndrome or placenta previa</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Greater resistance to flow (High PI) and diastolic notching  on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Greater resistance to flow (High PI) and diastolic notching  on a uterine artery Doppler at 11-14 weeks are predictors of Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Preeclampsia Gestational HTN Fetal growth restriction</li><li>\u27a4 Preeclampsia</li><li>\u27a4 Gestational HTN</li><li>\u27a4 Fetal growth restriction</li><li>\u27a4 Ref: Page no 214, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 214, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c13aa563",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman is at her second trimester prenatal visit. She inquires about screening for neural tube defects. Which prenatal screening test is used to assess the risk of neural tube defects, such as spina bifida, in the second trimester?",
      "options": [
        {
          "label": "A",
          "text": "Alpha-fetoprotein (AFP) screening",
          "correct": true
        },
        {
          "label": "B",
          "text": "Nuchal translucency ultrasound",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chorionic villus sampling (CVS)",
          "correct": false
        },
        {
          "label": "D",
          "text": "Amniocentesis",
          "correct": false
        }
      ],
      "correct_answer": "A. Alpha-fetoprotein (AFP) screening",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Alpha-fetoprotein (AFP) screening</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option B: Nuchal Translucency (NT): Done at 11-14 weeks as screening for Down syndrome. It is increased in fetuses with Down syndrome and also increased in other chromosomal abnormalities and congenital abnormalities like cardiac diseases. Option C & Option D: CVS and Amniocentesis are diagnostic techniques for detecting chromosomal abnormalities.</li><li>\u2022 Option B: Nuchal Translucency (NT): Done at 11-14 weeks as screening for Down syndrome. It is increased in fetuses with Down syndrome and also increased in other chromosomal abnormalities and congenital abnormalities like cardiac diseases.</li><li>\u2022 Option B:</li><li>\u2022 Option C & Option D: CVS and Amniocentesis are diagnostic techniques for detecting chromosomal abnormalities.</li><li>\u2022 Option C & Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 273, William\u2019s Obstetrics 25 th edition</li><li>\u27a4 Ref: Page no 273, William\u2019s Obstetrics 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "86fdc65f",
      "audio": ""
    },
    {
      "text": "A 23-year primigravida presents at 6 weeks with spotting. She is very anxious. On ultrasound, there is a single live intrauterine fetus corresponding to 6 weeks and cardiac activity is seen. She is reassured that this spotting could be normal and due to fusion of the decidua. What is this sign known as?",
      "options": [
        {
          "label": "A",
          "text": "Palmer sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "Piscacek\u2019s sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Placental sign",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hegar\u2019s sign",
          "correct": false
        }
      ],
      "correct_answer": "C. Placental sign",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/02.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Placental sign</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Placental sign is mild bleeding/ spotting which may be seen before complete fusion of the decidua vera with the decidua capsularis and is also called implantation bleed ; It may be cyclical and may last till 12 weeks.</li><li>\u2022 Placental sign</li><li>\u2022 also called implantation bleed</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Palmer sign, Piscacek\u2019s sign and Hegar sign are all clinical signs of pregnancy in the 1 st trimester</li><li>\u2022 Palmer sign, Piscacek\u2019s sign and Hegar sign are all clinical signs of pregnancy in the 1 st trimester</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The named signs in pregnancy are:</li><li>\u27a4 Ref: Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "224f2a86",
      "audio": ""
    },
    {
      "text": "A woman presents to the antenatal OPD. She is not sure of her dates. On abdominal examination, external ballottement is elicited. When is the earliest, this sign can be seen?",
      "options": [
        {
          "label": "A",
          "text": "6 \u2013 8 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "10 \u2013 12 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "14 \u2013 16 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "18 \u2013 20 weeks",
          "correct": true
        }
      ],
      "correct_answer": "D. 18 \u2013 20 weeks",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture2.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture3.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/picture4.jpg"
      ],
      "explanation": "<p><strong>Ans. D. 18-20 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 External Ballotment is as shown below. It appears at 18-20 weeks</li><li>\u2022 External Ballotment is as shown below. It appears at 18-20 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This is External Ballotment. External Ballottement can be elicited after 18-20 weeks by a push to the fetal parts with one hand abdominally and the other hand receiving the impulse</li><li>\u27a4 This is internal Ballottement. It can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix.</li><li>\u27a4 This is internal Ballottement. It can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix.</li><li>\u27a4 Ref: Page 62, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 62, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "573cadfe",
      "audio": ""
    },
    {
      "text": "A 27-year primigravida visits the antenatal OPD at 24 weeks. An intern examines the patient. Which is NOT an expected finding in this patient?",
      "options": [
        {
          "label": "A",
          "text": "External Ballotment",
          "correct": false
        },
        {
          "label": "B",
          "text": "Fetal Heart auscultated",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hegar\u2019s Sign",
          "correct": true
        },
        {
          "label": "D",
          "text": "The uterine fundus is palpated at the upper border of the umbilicus",
          "correct": false
        }
      ],
      "correct_answer": "C. Hegar\u2019s Sign",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hegar\u2019s sign</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In the 2 nd trimester, the following are seen:</li><li>\u27a4 On Inspection: Striae gravidarum and linea nigra are seen On Palpation: Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks External ballotment at 18-20 weeks Internal ballotment after 16 weeks Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 On Inspection: Striae gravidarum and linea nigra are seen</li><li>\u27a4 Striae gravidarum and linea nigra are seen</li><li>\u27a4 Striae gravidarum and linea nigra are seen</li><li>\u27a4 On Palpation: Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks External ballotment at 18-20 weeks Internal ballotment after 16 weeks Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks External ballotment at 18-20 weeks Internal ballotment after 16 weeks Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 Uterus palpable at 12 \u2013 14 weeks, lower border of umbilicus at 20 weeks and upper border at 24 weeks</li><li>\u27a4 External ballotment at 18-20 weeks</li><li>\u27a4 Internal ballotment after 16 weeks</li><li>\u27a4 Fetal Heart rate can be auscultated as early as 20 weeks</li><li>\u27a4 Ref: Page 64, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref: Page 64, DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b6a1f945",
      "audio": ""
    },
    {
      "text": "Match the following change with the period of gestation seen in?",
      "options": [
        {
          "label": "A",
          "text": "a4 b3 c2 d1",
          "correct": false
        },
        {
          "label": "B",
          "text": "a1 b3 c2 d4",
          "correct": false
        },
        {
          "label": "C",
          "text": "a2 b4 c3 d1",
          "correct": false
        },
        {
          "label": "D",
          "text": "a2 b3 c4 d1",
          "correct": true
        }
      ],
      "correct_answer": "D. a2 b3 c4 d1",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/033.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. a2 b3 c4 d1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks FHR is 1 st auscultated by stethoscope at 18-20 weeks Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li><li>\u2022 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks</li><li>\u2022 FHR is 1 st auscultated by stethoscope at 18-20 weeks</li><li>\u2022 Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks</li><li>\u2022 Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks FHR is 1 st auscultated by stethoscope at 18-20 weeks Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li><li>\u27a4 Internal Ballotment (can be elicited at 16 weeks by a push to the fetal parts with the two fingers through the anterior fornix):  seen between 16 \u2013 28 weeks</li><li>\u27a4 FHR is 1 st auscultated by stethoscope at 18-20 weeks</li><li>\u27a4 Hegar\u2019s sign (On bimanual exam, the abdominal and vaginal fingers approximate below the body of the uterus) is seen between 8 \u2013 12 weeks</li><li>\u27a4 Lightening occurs (Feeling of dropping down of the baby in the pelvis) at 38 weeks</li><li>\u27a4 Ref:  Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li><li>\u27a4 Ref:  Page 61; DC Dutta\u2019s Textbook of Obstetrics; 9 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0a611251",
      "audio": ""
    },
    {
      "text": "Identify the grip in the picture used for checking ballotability of head?",
      "options": [
        {
          "label": "A",
          "text": "Pelvic grip",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pawlick grip",
          "correct": true
        },
        {
          "label": "C",
          "text": "Fundal grip",
          "correct": false
        },
        {
          "label": "D",
          "text": "Umbilical grip",
          "correct": false
        }
      ],
      "correct_answer": "B. Pawlick grip",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/09/fmg-2.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/09/obg-26_WgYopAf.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Pawlick grip</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The image shows the #rd Leopold maneuver; also called the 1 st pelvic grip; also called the Pawlik grip.</li><li>\u2022 The image shows the #rd Leopold maneuver; also called the 1 st pelvic grip; also called the Pawlik grip.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 There are 4 Leopold Maneuvers:</li><li>\u27a4 Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts) The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation. The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 Fundal grip (A): to assess which fetal pole (cephalic or podalic) occupies the fundus. The breech gives the sensation of a large nodular mass; the head feel hard, round and mobile</li><li>\u27a4 Fundal grip (A):</li><li>\u27a4 The Lateral grip (B): determines the side of the back (hard, resistant) and the limbs (numerous, small irregular mobile parts)</li><li>\u27a4 The Lateral grip (B):</li><li>\u27a4 The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C): determining fetal presentation.</li><li>\u27a4 The 1 st pelvic grip (3 rd maneuver aka Pawlik grip - C):</li><li>\u27a4 The 2 nd pelvic grip (4 th maneuver - D): determines the degree of descent. This maneuver is done facing the feet of the patient and trying to approximate the hands of the examiner. IF the hands approximate; the head has not descended into the pelvis. If the hands diverge, the head has descended into the pelvis.</li><li>\u27a4 The 2 nd pelvic grip (4 th maneuver - D):</li><li>\u27a4 Ref: Page 424, William\u2019s Obstetrics; 25 th edition</li><li>\u27a4 Ref: Page 424, William\u2019s Obstetrics; 25 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abaeb55b",
      "audio": ""
    },
    {
      "text": "All are ultrasound signs of an unruptured ectopic pregnancy except?",
      "options": [
        {
          "label": "A",
          "text": "Bagel sign",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blob sign",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lemon sign",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tubal ring",
          "correct": false
        }
      ],
      "correct_answer": "C. Lemon sign",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c196b0e",
      "audio": ""
    }
  ]
}